Not without clinician guidance
Chronic pain lingers for months or years, often because of ongoing inflammation, nerve changes, or tissue that never fully healed
You can read the abstract of this article at In the SURPASS-4 trial, the dual GIP and GLP-1 receptor agonist tirzepatide demonstrated superior reductions in HbA1c concentrations, bodyweight, and blood pressure compared to titrated daily insulin glargine in individuals with type 2 diabetes and cardiovascular risk
We send letters to people and threaten them
Its especially common with Wegovy HD
However, a randomized controlled trial that compared once-a-week 2.4 mg of semaglutide to placebo in type 2 diabetes patients found that 67.5% of participants had an HbA1c lower than 48 mmol/mol (6.5%) at the end of 68 weeks